Isracann Biosciences Provides Bi-Weekly Default Status Report
13. Oktober 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that further to its news release dated...
Isracann Biosciences Announces Delay in Filing Annual Financial Statements
29. September 2022 18:25 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that the filing of its audited annual...
Isracann Bioscience Facilitated Genetics Arrive in Israel
28. September 2022 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted Israel-based company focused on...
Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel
14. September 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”), a multi-faceted Israel-based company focused on...
Praesidio signs distribution agreement with Pure Integrative Pharmacy
01. September 2022 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board
23. August 2022 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement
03. August 2022 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that it has closed the first...
Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada
19. Mai 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
Isracann Biosciences Renews Leadership to Meet Changing Demands
15. April 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that further to its...
Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers
13. April 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the...